Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma

CONCLUSION: Integrative machine learning analysis was performed to construct a novel IRS in cholangiocarcinoma. This IRS acted as an indicator for predicting the prognosis and immunotherapy benefits of cholangiocarcinoma patients.PMID:38387388 | DOI:10.1016/j.tranon.2024.101905

Source: Translational Oncology - February 22, 2024 Category: Cancer & Oncology Authors: Xu Chen Bo Sun Yu Chen Yili Xiao Yinghui Song Sulai Liu Chuang Peng Source Type: research